Title:
A curative medicine and a preventive medicine of tumor dissolution syndrome
Document Type and Number:
Japanese Patent JP5907396
Kind Code:
B2
Abstract:
The purpose of the present invention is to provide a novel therapeutic or prophylactic agent for tumor lysis syndrome. The present invention is a therapeutic or prophylactic agent for tumor lysis syndrome, which comprises a 2-phenylthiazole compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
Inventors:
Takanori Ueda
Takahiro Yamauchi
Mihoko Morita
Hideki Horiuchi
Takahiro Yamauchi
Mihoko Morita
Hideki Horiuchi
Application Number:
JP2014543303A
Publication Date:
April 26, 2016
Filing Date:
October 22, 2013
Export Citation:
Assignee:
National University Corporation Fukui University
Teijin Pharma Limited
Teijin Pharma Limited
International Classes:
A61K31/426; A61K31/454; A61K31/496; A61K31/5377; A61P13/04; A61P13/12; A61P35/00; A61P39/00
Domestic Patent References:
| JP2010509372A | 2010-03-25 | |||
| JP2010509372A | 2010-03-25 |
Foreign References:
| WO1992009279A1 | 1992-06-11 |
Other References:
JPN6013056648; 山内高広 他: '腫瘍領域における高尿酸血症とその病態・治療-腫瘍崩壊症候群を中心に-' 日本痛風・核酸代謝学会総会プログラム・抄録集 Ｖｏｌ．４５ｔｈ, 20120216, ｐ．４２
JPN6013056651; 上田孝典 他: '痛風Ｑ＆Ａ 腫瘍融解症候群におけるウリカーゼ療法の長所と短所を教えてください' 高尿酸血症と痛風 Ｖｏｌ．２０， Ｎｏ．２, 20120920, ｐ．１８６-１８７
JPN6013056654; ＴＩＵ，Ｒ．Ｖ． ｅｔ ａｌ: 'Ｔｕｍｏｒ Ｌｙｓｉｓ Ｓｙｎｄｒｏｍｅ' ＳＥＭＩＮＡＲＳ ＩＮ ＴＨＲＯＭＢＯＳＩＳ ＡＮＤ ＨＥＭＯＳＴＡＳＩＳ Ｖｏｌ．３３， Ｎｏ．４, 2007, ｐ．３９７-４０７
JPN6013056651; 上田孝典 他: '痛風Ｑ＆Ａ 腫瘍融解症候群におけるウリカーゼ療法の長所と短所を教えてください' 高尿酸血症と痛風 Ｖｏｌ．２０， Ｎｏ．２, 20120920, ｐ．１８６-１８７
JPN6013056654; ＴＩＵ，Ｒ．Ｖ． ｅｔ ａｌ: 'Ｔｕｍｏｒ Ｌｙｓｉｓ Ｓｙｎｄｒｏｍｅ' ＳＥＭＩＮＡＲＳ ＩＮ ＴＨＲＯＭＢＯＳＩＳ ＡＮＤ ＨＥＭＯＳＴＡＳＩＳ Ｖｏｌ．３３， Ｎｏ．４, 2007, ｐ．３９７-４０７
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazuhiro Nakamura
Yoichi Watanabe
Masaru Nakajima
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazuhiro Nakamura
Yoichi Watanabe
Masaru Nakajima